Endpoints News
Cytokinetics' heart drug PDUFA delayed Read in browser
Endpoints News
Thank you for reading, dupa dupackia!
basic
UPGRADE
M T W Th Fri
2 May, 2025
LGBTQ+ LEADERS IN BIOPHARMA '25
Who are the LGBTQ+ leaders in the industry? Hear insights from the honorees giving voice and visibility to the LGBTQ+ presence in biopharma — join virtually and celebrate with us. Sign up now.
presented by Rivus Pharmaceuticals
Rev­o­lu­tion­iz­ing obe­si­ty treat­ment: Could mi­to­chon­dria hold the key to un­lock­ing fat-spe­cif­ic weight loss?
spotlight
In Focus
US drugmakers increasingly look abroad for clinical trials as confidence in FDA wavers
ENDPOINTS NEWS
news
In Focus
The inside story of how SalioGen, a startup trying to wrangle ‘jumping genes’ to make medicines, fell apart
ENDPOINTS NEWS
Missing REMS delays Cytokinetics' heart drug PDUFA, stock drops
ENDPOINTS NEWS
Investors unveil plans for $1.3B cancer hub in London suburbs
ENDPOINTS NEWS
Peer Review
Former Tome CEO joins Flagship startup; NGM Bio chief steps down as restructuring takes effect
ENDPOINTS NEWS
Amgen says FDA hold is lifted on its Phase 1 obesity candidate as MariTide enters Phase 3
ENDPOINTS NEWS
Bristol Myers to close cell therapy site in Illinois as part of ongoing cost cuts
ENDPOINTS NEWS
Endpoints Careers
Research Associate I/II - Gene Therapy
MeiraGTx
New York, NY, USA
Senior Drug Development Clinician
Weatherden
London, UK
Head of Clinical Operations
ModeX Therapeutics Inc.
Weston, MA 02493, USA
Senior Scientist, Analytical Development
Precision BioSciences
Durham, NC
Recruit talent with Endpoints Careers
Contact Meg Estacio: mestacio@endpointsnews.com
Taking the next steps with your drug in Japan -  Register Now
Exploring Japan as a key market for your drug? Get the roadmap — join senior Japanese leaders to hear firsthand on the regulatory and pricing dynamics behind one of the world’s top pharma markets. Sign up now.
endpoints pharma
RFK Jr. claims placebo-controlled vaccine trials are 'radical departure' from past. Experts disagree
ENDPOINTS NEWS
 
HHS launches $500M universal vaccine platform as RFK Jr. shakes up US vaccine policy
ENDPOINTS NEWS
Lilly CEO Ricks urges Trump to drop drug tariff plan
ENDPOINTS NEWS
Moderna, facing revenue misses and political headwinds, disappoints Wall Street
ENDPOINTS NEWS
 
Moderna expands effort to rein in costs in an ‘uncertain environment’
ENDPOINTS NEWS
FDA adcomms slated to review data on long-term opioid use, overdoses
ENDPOINTS NEWS
Endpoints webinars
May 12
1:30pm ET
How to incorporate pragmatic design elements into your clinical studies
Flatiron
May 29